VR Logo

United Therapeutics Corporation (UTHR) download report


Healthcare | Biotechnology & Pharma Research

United Therapeutics Corporation (UTHR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

IPO Date: 17-Jun-1999

Founder, Chairman & CEO: Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.

Pres & COO: Mr. Michael I. Benkowitz

Listing: NASDAQ: UTHR

Country: United States

Headquarters: Silver Spring, MD

Website: https://www.unither.com

Key Facts

Market cap: $10,824.31 Mln

Revenue (TTM): $1,768.30 Mln

Earnings (TTM): $687.40 Mln

Cash: $2,267.70 Mln

Total Debt: $800.00 Mln

Insider's Holding: 1.77%

Liquidity: Low

52 Week range: $158.38 - 243.16

Shares outstanding: 45,299,500

10 Years Aggregate:

  • CFO: $4,529.72 Mln
  • EBITDA: $6,233.69 Mln
  • Net Profit: $4,076.82 Mln

Stock Performance

Time Period United Therapeutics (UTHR) S&P BSE Sensex S&P Midcap 400
YTD11.14-8.71-17.21
1 month1.84-3.11-7.36
3 months37.36-7.30-13.26
1 Year33.420.48-13.71
3 Years46.1010.346.97
5 Years12.9011.436.26
10 Years17.2012.109.93
As on 28-Jun-2022
Year United Therapeutics (UTHR) S&P Midcap 400 S&P BSE Sensex
202142.3523.2121.99
202072.3311.8115.75
2019-19.1224.0514.38
2018-26.27-12.435.87
20173.1514.4527.91
2016-8.4218.731.95
201520.94-3.71-5.03